Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cytosorbents Cor (NQ: CTSO ) 0.8622 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EST, Nov 5, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Cytosorbents Cor < Previous 1 2 3 4 5 Next > CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification November 04, 2024 From CytoSorbents Via GlobeNewswire Analyst Scoreboard: 5 Ratings For CytoSorbents October 22, 2024 Via Benzinga Expert Outlook: CytoSorbents Through The Eyes Of 5 Analysts October 22, 2024 Via Benzinga FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review October 22, 2024 DrugSorb™-ATR is an FDA Breakthrough Device eligible for priority review with an FDA decision anticipated in 2025 From CytoSorbents Via GlobeNewswire Recap: CytoSorbents Q4 Earnings March 14, 2024 Via Benzinga CytoSorbents to Report Third Quarter 2024 Operating and Financial Results October 17, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update October 01, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference August 27, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 16, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Beats EPS, Beats Revenue for Q2 2024 August 13, 2024 CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024. Via InvestorPlace CytoSorbents Reports Second Quarter 2024 Financial and Operational Results August 13, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Appoints Peter J. Mariani Chief Financial Officer August 13, 2024 CytoSorbents CFO Kathleen P. Bloch Retires From CytoSorbents Via GlobeNewswire CytoSorbents to Report Second Quarter 2024 Operating and Financial Results August 07, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement August 01, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website July 29, 2024 “Working to Save Lives Together” Theme Highlights Two Decades of Successful Collaboration with the International Medical and Research Communities to Help Patients Survive Life-Threatening Illnesses From CytoSorbents Via GlobeNewswire CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress July 17, 2024 From CytoSorbents Via GlobeNewswire Why CytoSorbents (CTSO) Stock Is Trading Higher July 02, 2024 CytoSorbents shares are trading higher by 20% during Tuesday's session. The company entered into a new $20 million credit facility with Avenue Capital Group. Via Benzinga CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union June 13, 2024 By enabling more rapid and easy treatment, PuriFi is expected to increase the demand and sales of CytoSorbents’ leading CytoSorb® blood purification cartridge for critically ill patients in the... From CytoSorbents Via GlobeNewswire CytoSorbents Secures $20 Million Credit Facility July 02, 2024 Credit facility provides timely non-dilutive capital to support ongoing global commercialization of CytoSorb® as well as regulatory submissions and potential commercialization plans for DrugSorb™-ATR... From CytoSorbents Via GlobeNewswire CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting June 05, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan June 24, 2024 Brings a powerful blood purification technology used to treat critically ill and cardiac surgery patients in nearly a quarter million treatments across 75 countries to date to one of the most... From CytoSorbents Via GlobeNewswire CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract June 04, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Meets EPS, Beats Revenue for Q1 2024 May 09, 2024 CTSO stock results show that CytoSorbents met analyst estimates for earnings per share but beat on revenue for the first quarter of 2024. Via InvestorPlace CytoSorbents Reports First Quarter 2024 Results May 09, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe May 02, 2024 From CytoSorbents Via GlobeNewswire CytoSorbents to Report First Quarter 2024 Operating and Financial Results April 26, 2024 From CytoSorbents Via GlobeNewswire STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting April 17, 2024 From CytoSorbents Via GlobeNewswire CTSO Stock Earnings: CytoSorbents Beats EPS, Misses Revenue for Q4 2023 March 14, 2024 CTSO stock results show that CytoSorbents beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. Via InvestorPlace CytoSorbents Reports Fourth Quarter and Full Year 2023 Results March 14, 2024 From CytoSorbents Via GlobeNewswire Earnings Scheduled For March 14, 2024 March 14, 2024 Companies Reporting Before The Bell • Pharming (NASDAQ:PHAR) is projected to report earnings for its fourth quarter. Via Benzinga < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
